Expert: 'We Cannot Overstate or Ignore' Relationship Between Diabetes, COVID-19 Infection Risk
Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses how the diabetes DRIVE program compares with the SHC DRIVE models for flu and COVID-19 vaccinations.
Pharmacy Times interviewed Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity, on some new approaches to address racial and ethnic disparities in diabetes care.
During the discussion, Hall explained how the diabetes DRIVE program compares with the SHC DRIVE models aimed at improving flu and COVID-19 vaccination rates.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma
September 19th 2025
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025